Home/Pipeline/Anti-malarial Portfolio (ACTs)

Anti-malarial Portfolio (ACTs)

Malaria

ApprovedMarketed

Key Facts

Indication

Malaria

Phase

Approved

Status

Marketed

Company

Bliss GVS Pharma

About Bliss GVS Pharma

Bliss GVS Pharma is a vertically integrated pharmaceutical company with core strengths in anti-malarials, anti-infectives, and a growing portfolio in other therapeutic areas. The company operates through its manufacturing facilities in India and has established a strong commercial footprint in over 70 countries. Its strategic direction involves expanding its product portfolio through in-house R&D and strategic partnerships, while leveraging its manufacturing capabilities to serve regulated and semi-regulated markets.

View full company profile

Therapeutic Areas

Anti-malarial Anti-infective Pain Management Gastrointestinal Nutraceuticals

Other Malaria Drugs

Drug	Company	Phase	Status
Chloroquine Phosphate	Ipca Laboratories	Commercial	Active
Malaria Vaccine (R21/Matrix-M)	Novavax	Phase 3	WHO Recommended
Anti-malarial Portfolio	Strides Pharma	Approved	Commercial
STANDARD Q Malaria Pf/Pan Ag Test	SD BioSensor	Approved	Commercial